• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Monocyte to macrophage differentiation protein (MMD), Truncated

ACP08422

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP08422 Target NameMMD
Target SynonymsMMD; PAQR11; Monocyte to macrophage differentiation factor; Progestin and adipoQ receptor family member 11; Progestin and adipoQ receptor family member XIFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ15546
Background Information
  • Uniprot Id

    Q15546

  • Target Species

    Human

  • Target Name

    MMD

  • Target Full Name

    Monocyte to macrophage differentiation factor

  • Target Function

    Involved in the dynamics of lysosomal membranes associated with microglial activation following brain lesion.

  • Target Subcellular Location

    Late endosome membrane; Multi-pass membrane protein. Lysosome membrane; Multi-pass membrane protein.

  • Target Protein Families

    ADIPOR family

  • Target Tissue Specificity

    Exhibits relatively ubiquitous expression with preferential expression in mature (in vitro differentiated) macrophages.

  • Target Synonyms

    MMD; PAQR11; Monocyte to macrophage differentiation factor; Progestin and adipoQ receptor family member 11; Progestin and adipoQ receptor family member XI

Inquire Recombinant Human Monocyte to macrophage differentiation protein (MMD), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification